C07K 5/0802
With the first amino acid being neutral
Official title: {with the first amino acid being neutral}
C07K5/0802 (With the first amino acid being neutral) appears on 1,744 US grants and 1,805 published applications in this corpus.
Search patents in C07K- Granted patents
- 1,744
- Published applications
- 1,805
- Assignees
- 982
- Inventors
- 4,535
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 6 | 0 |
| 1978 | 13 | 0 |
| 1979 | 9 | 0 |
| 1980 | 23 | 0 |
| 1981 | 20 | 0 |
| 1982 | 17 | 0 |
| 1983 | 9 | 0 |
| 1984 | 22 | 0 |
| 1985 | 13 | 0 |
| 1986 | 11 | 0 |
| 1987 | 18 | 0 |
| 1988 | 13 | 0 |
| 1989 | 12 | 0 |
| 1990 | 9 | 0 |
| 1991 | 13 | 0 |
| 1992 | 20 | 0 |
| 1993 | 21 | 0 |
| 1994 | 15 | 0 |
| 1995 | 23 | 0 |
| 1996 | 35 | 0 |
| 1997 | 36 | 0 |
| 1998 | 65 | 0 |
| 1999 | 47 | 0 |
| 2000 | 62 | 0 |
| 2001 | 36 | 6 |
| 2002 | 35 | 39 |
| 2003 | 39 | 76 |
| 2004 | 29 | 67 |
| 2005 | 27 | 69 |
| 2006 | 50 | 70 |
| 2007 | 47 | 89 |
| 2008 | 35 | 90 |
| 2009 | 57 | 116 |
| 2010 | 59 | 90 |
| 2011 | 56 | 81 |
| 2012 | 68 | 92 |
| 2013 | 74 | 85 |
| 2014 | 72 | 89 |
| 2015 | 67 | 85 |
| 2016 | 82 | 72 |
| 2017 | 51 | 82 |
| 2018 | 53 | 62 |
| 2019 | 43 | 66 |
| 2020 | 39 | 60 |
| 2021 | 51 | 53 |
| 2022 | 29 | 56 |
| 2023 | 23 | 51 |
| 2024 | 36 | 74 |
| 2025 | 35 | 52 |
| 2026 | 13 | 33 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Peptide, cell growth promoter, protein production promoter, culture medium, cell growth method using peptide, and protein production method using peptide15 Sep 2026US 12,735,451 B2Maruhachi Muramatsu, Inc.
- Small molecule inhibitors of SARS-CoV-2 viral replication and uses thereof25 Aug 2026US 12,715,896 B2Arizona Board of Regents on Behalf of the University of Arizona
- Molecules18 Aug 2026US 12,709,596 B2Ena Respiratory Pty Ltd
- Method to enhance the efficiency of systemic AAV gene delivery to the central nervous system23 Jun 2026US 12,661,412 B2University of Massachusetts
- Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers16 Jun 2026US 12,655,178 B2Rhythm Pharmaceuticals, Inc.
- Universal abt compounds and uses thereof24 Sep 2026US 2026/0284204 A1Kleo Pharmaceuticals, Inc.
- Macrocyclic broad spectrum antibiotics17 Sep 2026US 2026/0274892 A1Genentech, Inc.
- Peptide substrates and inhibitors of cathepsin b10 Sep 2026US 2026/0265298 A1The Regents of the University of California
- Production method for induced pluripotent stem cells27 Aug 2026US 2026/0250638 A1Sekisui Chemical Co., Ltd.
- Ptp1b/tc-ptp dual inhibitors and protein degraders20 Aug 2026US 2026/0240878 A1Purdue Research Foundation
Most cited
By later US patents
- Lysosomal enzyme-cleavable antitumor drug conjugates653US 6,214,345 B1Bristol-Myers Squibb Company · 2001
- Antibody-therapeutic agent conjugates288US 4,867,973 ACytogen Corporation · 1989
- Methods for identifying RNA binding compounds220US 6,503,713 B1University of Medicine and Dentistry of New Jersey · 2003
- Macrocyclic peptides active against the hepatitis C virus199US 6,608,027 B1Boehringer Ingelheim (Canada) Ltd. · 2003
- Peptide library and screening systems197US 5,432,018 AAffymax Technologies N.V. · 1995